Cancer Tx Eye Toxicity; ASCO Targets Preauthorization; Liver Transplant for Seniors

[MEDPAGE TODAY]( Oncology Update Friday, July 29, 2022 [Cancer Tx Eye Toxicity; ASCO Targets Preauthorization; Liver Transplant for Seniors]( [Another Possible Use for Aspirin: Reducing Ovarian Cancer Risk]( [TKI Plus Immunotherapy Active in Melanoma After Anti-PD-1 Progression]( ['Rogue' Online Pharmacies Are Dispensing Cancer Drugs]( [Jared Kushner's Thyroid Cancer]( ADVERTISEMENT Exclusives & Features [Simone Gold, of America's Frontline Doctors, Reports to Federal Prison]( [Deadly Bacteria in U.S. Soil Not Tied to Lab Leak, Aromatherapy]( [Here's Where Private Equity Is Most Involved in Medicine]( [These Advancements Are Improving Prognoses for People With Bladder Cancer]( Refinements in chemotherapies, radiation treatments, and surgery are improving prognoses for people with bladder cancer. [READ MORE]( [A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.]( BACKGROUND: Gemcitabine and cisplatin has limited benefit as treatment for advanced biliary tract cancer (BTC). The addition of an anti-programmed death receptor (PD-1)/PD-ligand (L1) antibody to... [READ MORE]( [Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia.]( We have developed a deep-scale proteome and phosphoproteome database from 44 representative Acute Myeloid Leukemia (AML) patients from the LAML TCGA dataset, and 6 healthy bone marrow derived... [READ MORE]( [FDA Accepts sBLA of Trastuzumab Deruxtecan for Treatment of Individuals With HER2-Low Breast Cancer]( Trastuzumab deruxtecan is an engineered HER2-directed antibody drug conjugate being jointly developed and commercialized by AstraZeneca and Daiichi Sankyo. [READ MORE]( [Brain tumor gene also causes childhood cancers, study finds]( A gene that is responsible for the deadliest type of brain tumor is also responsible for two forms of rhabdomyosarcoma, a childhood cancer affecting soft tissue, researchers at Charlottesville,... [READ MORE]( [A Property of Everyday Health group]( © 2022 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2022-07-29&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014